Rosanortriterpenes A–B, Two Promising Agents from Rosa laevigata var. leiocapus, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models

• Published in: Evidence-based complementary and alternative medicine Vol. 2020; no. 2020; pp. 1 - 9
• Main Authors: Wu, Jie-Wei, Li, Qian-Ran, Liang, Hui-Jun, Ni, Chen, Xie, Jin-Dan, Hu, Juan-Juan, Li, Bai-Lin, Yuan, Jie
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 2020; Hindawi; Hindawi Limited
• Subjects: Cell adhesion & migration; Cell culture; Cytotoxicity; Fibrosis; Fruits; Hepatitis; Inflammation; Interleukin 6; Liver; Liver diseases; Macrophages; Microscopy; NF-κB protein; Nitric oxide; Nonsteroidal anti-inflammatory drugs; Penicillin; Proteins; Rosa laevigata; Tumor necrosis factor-α; Tumors; Variance analysis; United States > US; Massachusetts; China
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2020/8872945

Rosanortriterpenes A–B (RTA and RTB), two nortriterpenoids, are characteristic constituents in the fruits of Rosa laevigata var. leiocapus. However, pharmacological studies on these compounds are still scarce. In the present study, we aim to investigate the anti-inflammatory mechanisms associated with the effects of RTA–B in RAW264.7 macrophages and LO2 cells by detecting cell viabilities, nitric oxide (NO) production, tumour necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) production. Simultaneously, the anti-inflammatory action mechanisms of these two compounds were illustrated through western blot assay. Besides, the antihepatic fibrosis activities of these compounds have also been explored. The results demonstrated that RTA and RTB inhibited the production of NO, TNF-α, and IL-6 and suppressed liver fibrosis. RTA and RTB treatment also greatly inhibited the activation of NF-kappaB (NF-κB) pathway. Our study confirmed the promising anti-inflammatory and anti-liver fibrosis actions of RTA–B, suggesting that they might be developed as alternative and promising drugs for the treatment of hepatic inflammatory and fibrotic diseases.